A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis

被引：0
作者：
W. Colby Brown
Brent Senior
机构：
[1] University of North Carolina,Department of Otolaryngology
来源：
Current Allergy and Asthma Reports | 2020年 / 20卷
关键词：
Chronic rhinosinusitis; Nasal polyps; Monoclonal antibodies; Biologics; Cost-efficacy; Dupilumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 225 条
  • [1] Orlandi RR(2016)International consensus statement on allergy and rhinology: Rhinosinusitis executive summary Int Forum Allergy Rhinol 6 S3-21
  • [2] Kingdom TT(2017)The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps Lancet. 15 1035-1044
  • [3] Hwang PH(2019)A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps Ann Allergy Asthma Immunol American College of Allergy, Asthma and Immunology 123 232-239
  • [4] Scangas GA(2020)European position paper on rhinosinusitis and nasal polyps 2020 Rhinol J 58 1-464
  • [5] Remenschneider AK(2017)Economics of chronic rhinosinusitis Curr Allergy Asthma Rep 17 20-423
  • [6] Su BM(2018)Biologics in chronic rhinosinusitis: an update and thoughts for future directions Am J Rhinol Allergy 32 412-32
  • [7] Shrime MG(2015)Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis Laryngoscope. 125 25-37
  • [8] Metson R(2017)Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis Laryngoscope. 127 29-142
  • [9] Bachert C(2018)Two decades with omalizumab: what we still have to learn Biol Targets Ther 12 135-6
  • [10] Codispoti CD(2019)Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art World Allergy Organ J 12 1-211
12345678910